Fundraising Fox
/Companies
Sign in

Matchpoint Therapeutics

Cambridge, US · Founded 2021 · 6 known investors

Find your way into Matchpoint Therapeutics

Sign up to see every warm intro you have to Matchpoint Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Matchpoint Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

Biotech

Founders & leadership

AT
Andre TurenneExecutive

Board

JHJason Hafler
Jason HaflerBoard directorManaging Director at Sanofi Ventures
BB
Bruce BoothBoard director
DB
Daniel BeckerBoard director

Investors · 6

Digitalis Ventureslisted by Digitalis VenturesNew York · $100K – $10M

How we know: Digitalis Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M

How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

Access IndustriesreportedNew York

How we know: a partner's Signal profile · Not right? Tell us

AlexandriareportedPasadena

How we know: funding news · Not right? Tell us

Atlas VenturereportedCambridge · $500K – $1M

How we know: a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$42M disclosed across 1 round · 2022

▶$42MraisedOct 2022 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason HaflerDirector
  • Andre TurenneExecutive Officer, Director
  • Bruce BoothDirector
  • Daniel BeckerDirector
Offering amount
$70M
Amount sold
$42M
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Matchpoint Therapeutics do?
Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.
Who are Matchpoint Therapeutics's investors?
Matchpoint Therapeutics's investors include Access Biotechnology, Digitalis Ventures, Sanofi Ventures, Access Industries, Alexandria, Atlas Venture.
How much funding has Matchpoint Therapeutics raised?
Matchpoint Therapeutics has disclosed $42M raised across 1 round.
Where is Matchpoint Therapeutics headquartered?
Matchpoint Therapeutics is headquartered in Cambridge, US.